Abstract
IntroductionDiabetes is a disease characterized by insulin deficiency resulting in glucose intolerance and in abnormalities of other metabolic fuels including protein. Recently, a number of studies have revealed that branched-chain amino acids (BCAAs) (leucine, isoleucine, and valine) play an important role in the regulation of protein synthesis by activating mammalian target of rapamycin (mTOR) in pancreatic β cells. BCAAs have positive effects on the regulation of glucose homeostasis. Leucine is an important nutrient signal as evidenced by recent observations, which showed increased fasting concentrations of circulating BCAAs being associated with an increased risk of type 2 diabetes (T2D) and insulin resistance in humans. Leucine seems to have direct effects on hypothalamic and brainstem functioning involved in satiety, which can potentially contribute to obesity and T2D. A number of observational studies indicate that elevated activity of BCAAs could be associated with poor metabolic health and T2D complications. Although these associations were consistently observed in humans, the mechanisms underlying this relationship remain to be completely understood. In this study, we have attempted to evaluate urinary excretion of leucine among patients of T2D and compared them with healthy controls by using a low-cost and non-invasive amino acid chromatography technique.MethodsThe study was carried out in the Department of Biochemistry, Central Research Unit, Prathima Institute of Medical Sciences (PIMS), Karimnagar, Telangana, India, during the period between July and September 2016. A group of 55 normal healthy subjects (control group A), and 55 patients suffering from T2D on treatment (test group B), were enrolled in the study. The urine samples were collected from normal and T2D subjects. Thin-layer chromatography (TLC) for leucine was performed on all the urine samples.ResultsA strong correlation (p=0.0004) was found between the urinary excretion of leucine among the control (Rf=0.174 ±0.089) and T2D (Rf=0.247 ±0.030) patients.ConclusionExcretion of BCAAs (leucine) in detectable and increased quantities reflect the presence of an altered metabolic state attributable to T2D, which in turn could lead to early diabetic complications. This method (TLC), being non-invasive and cost-effective, could be recommended for assessing the progression and management of type 2 diabetes patients.
Highlights
Diabetes is a disease characterized by insulin deficiency resulting in glucose intolerance and in abnormalities of other metabolic fuels including protein
A number of studies have revealed that branched-chain amino acids (BCAAs) play an important role in the regulation of protein synthesis by activating mammalian target of rapamycin in pancreatic β cells
Leucine stimulates β cell proliferation via nutrient signaling, activates Rag guanosine triphosphatases (GTPases), activates mammalian target of rapamycin complex 1, and increases translational protein activity, which forms a hallmark feature of type 2 diabetes (T2D) as evidenced from studies in experimental mice [9]
Summary
Diabetes is a disease characterized by insulin deficiency resulting in glucose intolerance and in abnormalities of other metabolic fuels including protein. A number of studies have revealed that branched-chain amino acids (BCAAs) (leucine, isoleucine, and valine) play an important role in the regulation of protein synthesis by activating mammalian target of rapamycin (mTOR) in pancreatic β cells. Leucine is an important nutrient signal as evidenced by recent observations, which showed increased fasting concentrations of circulating BCAAs being associated with an increased risk of type 2 diabetes (T2D) and insulin resistance in humans. A number of observational studies indicate that elevated activity of BCAAs could be associated with poor metabolic health and T2D complications. These associations were consistently observed in humans, the mechanisms underlying this relationship remain to be completely understood. We have attempted to evaluate urinary excretion of leucine among patients of T2D and compared them with healthy controls by using a low-cost and non-invasive amino acid chromatography technique
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
